These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15708628)

  • 1. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.
    Breese GR; Knapp DJ; Criswell HE; Moy SS; Papadeas ST; Blake BL
    Brain Res Brain Res Rev; 2005 Feb; 48(1):57-73. PubMed ID: 15708628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal destruction of dopaminergic neurons.
    Breese GR; Criswell HE; Johnson KB; O'Callaghan JP; Duncan GE; Jensen KF; Simson PE; Mueller RA
    Neurotoxicology; 1994; 15(1):149-59. PubMed ID: 8090354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine.
    Criswell H; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.
    Ampe B; Massie A; D'Haens J; Ebinger G; Michotte Y; Sarre S
    J Neurochem; 2007 Nov; 103(3):1063-74. PubMed ID: 17727638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats.
    Taymans JM; Kia HK; Groenewegen HJ; Leysen JE; Langlois X
    Neuroscience; 2005; 134(2):643-56. PubMed ID: 15964700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
    Zhen X; Goswami S; Friedman E
    Pharmacol Biochem Behav; 2005 Apr; 80(4):597-601. PubMed ID: 15820529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat.
    Breese GR; Criswell HE; Duncan GE; Mueller RA
    Brain Res Bull; 1990 Sep; 25(3):477-84. PubMed ID: 2127238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study.
    Kitta T; Matsumoto M; Tanaka H; Mitsui T; Yoshioka M; Nonomura K
    Eur J Neurosci; 2008 Jun; 27(12):3216-25. PubMed ID: 18554296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.
    Zhang K; Tarazi FI; Baldessarini RJ
    Neuropsychopharmacology; 2001 Nov; 25(5):624-32. PubMed ID: 11682245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
    Sivam SP; Cox J
    Brain Res; 2006 Feb; 1073-1074():159-63. PubMed ID: 16455064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
    Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
    Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin tetrapeptide improves water maze performance of neonatally 6-hydroxydopamine-lesioned young rats.
    Rex A; Fink H
    Pharmacol Biochem Behav; 2004 Sep; 79(1):109-17. PubMed ID: 15388290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine deficiency in self-injurious behavior.
    Breese GR; Criswell HE; Duncan GE; Mueller RA
    Psychopharmacol Bull; 1989; 25(3):353-7. PubMed ID: 2697009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.